智通财经APP讯，东方生物(688298.SH)发布公告，公司及子公司杭州深度生物科技有限公司近日取得医疗器械注册证(体外诊断试剂)，全自动免疫印记分析仪主要用于过敏源检测试剂、自免检测试剂等配套使用。
PSA证书的取得，进一步丰富了公司在欧盟肿瘤标志物检测领域的技术路径及产品系列，主要用于前列腺癌的检测和患者筛查、复发检测、诊断后监测和治疗监测等管理。上述产品的取证有利于国内外市场的整体拓展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.